120 related articles for article (PubMed ID: 19302842)
21. Genetic diagnosis of alveolar rhabdomyosarcoma in the bone marrow of a patient without evidence of primary tumor.
Lisboa S; Cerveira N; Vieira J; Torres L; Ferreira AM; Afonso M; Norton L; Henrique R; Teixeira MR
Pediatr Blood Cancer; 2008 Oct; 51(4):554-7. PubMed ID: 18561177
[TBL] [Abstract][Full Text] [Related]
22. Multimodal genetic diagnosis of solid variant alveolar rhabdomyosarcoma.
Cerveira N; Torres L; Ribeiro FR; Henrique R; Pinto A; Bizarro S; Ferreira AM; Lopes C; Teixeira MR
Cancer Genet Cytogenet; 2005 Dec; 163(2):138-43. PubMed ID: 16337856
[TBL] [Abstract][Full Text] [Related]
23. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
Kelly KM; Womer RB; Sorensen PH; Xiong QB; Barr FG
J Clin Oncol; 1997 May; 15(5):1831-6. PubMed ID: 9164192
[TBL] [Abstract][Full Text] [Related]
24. Congenital alveolar rhabdomyosarcoma: clinical and molecular distinction from alveolar rhabdomyosarcoma in older children.
Grundy R; Anderson J; Gaze M; Gerrard M; Glaser A; Gordon A; Malone M; Pritchard-Jones K; Michalski A
Cancer; 2001 Feb; 91(3):606-12. PubMed ID: 11169945
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of Beckwith-Wiedemann syndrome in children presenting with Wilms tumor.
MacFarland SP; Duffy KA; Bhatti TR; Bagatell R; Balamuth NJ; Brodeur GM; Ganguly A; Mattei PA; Surrey LF; Balis FM; Kalish JM
Pediatr Blood Cancer; 2018 Oct; 65(10):e27296. PubMed ID: 29932284
[TBL] [Abstract][Full Text] [Related]
26. Alveolar rhabdomyosarcoma: morphoproteomics and personalized tumor graft testing further define the biology of PAX3-FKHR(FOXO1) subtype and provide targeted therapeutic options.
Brown RE; Buryanek J; Katz AM; Paz K; Wolff JE
Oncotarget; 2016 Jul; 7(29):46263-46272. PubMed ID: 27323832
[TBL] [Abstract][Full Text] [Related]
27. Beckwith-Weidemann syndrome with IC2 (KvDMR1) hypomethylation defect: a novel mutation.
Pandita A; Gupta S; Gupta G; Panghal A
BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29602885
[TBL] [Abstract][Full Text] [Related]
28. Detection of PAX3-FKHR and PAX7-FKHR fusion transcripts in rhabdomyosarcoma by reverse transcriptase-polymerase chain reaction using paraffin-embedded tissue.
Chen BF; Chen ML; Liang DC; Huang YW; Liu HC; Chen SH
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Feb; 62(2):86-91. PubMed ID: 10063718
[TBL] [Abstract][Full Text] [Related]
29. ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status.
Corao DA; Biegel JA; Coffin CM; Barr FG; Wainwright LM; Ernst LM; Choi JK; Zhang PJ; Pawel BR
Pediatr Dev Pathol; 2009; 12(4):275-83. PubMed ID: 18788887
[TBL] [Abstract][Full Text] [Related]
30. Normal and rearranged PAX3 expression in human rhabdomyosarcoma.
Frascella E; Toffolatti L; Rosolen A
Cancer Genet Cytogenet; 1998 Apr; 102(2):104-9. PubMed ID: 9546061
[TBL] [Abstract][Full Text] [Related]
31. Alveolar rhabdomyosarcoma after treatment of osteosarcoma.
Kasahara Y; Iwabuchi H; Takachi T; Hosokai R; Yoshida S; Imamura M; Watanabe A; Umezu H; Hotta T; Ogose A; Imai C
Pediatr Int; 2013 Aug; 55(4):527-30. PubMed ID: 23910806
[TBL] [Abstract][Full Text] [Related]
32. Primary alveolar rhabdomyosarcoma of the bone: two cases and review of the literature.
Balogh P; Bánusz R; Csóka M; Váradi Z; Varga E; Sápi Z
Diagn Pathol; 2016 Oct; 11(1):99. PubMed ID: 27756397
[TBL] [Abstract][Full Text] [Related]
33. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes.
Bridge JA; Liu J; Qualman SJ; Suijkerbuijk R; Wenger G; Zhang J; Wan X; Baker KS; Sorensen P; Barr FG
Genes Chromosomes Cancer; 2002 Mar; 33(3):310-21. PubMed ID: 11807989
[TBL] [Abstract][Full Text] [Related]
34. Incomplete Beckwith-Wiedemann syndrome in a child with orbital rhabdomyosarcoma.
Thavaraj V; Sethi A; Arya LS
Indian Pediatr; 2002 Mar; 39(3):299-304. PubMed ID: 11910143
[No Abstract] [Full Text] [Related]
35. Pleural Alveolar Rhabdomyosarcoma.
Lu H; Qin J; Wang Z
Clin Lab; 2017 Oct; 63(10):1745-1748. PubMed ID: 29035460
[TBL] [Abstract][Full Text] [Related]
36. Rhabdomyosarcoma: molecular diagnostics of patients classified by morphology and immunohistochemistry with emphasis on bone marrow and purged peripheral blood progenitor cells involvement.
Krsková L; Mrhalová M; Sumerauer D; Kodet R
Virchows Arch; 2006 Apr; 448(4):449-58. PubMed ID: 16365729
[TBL] [Abstract][Full Text] [Related]
37. Alveolar rhabdomyosarcoma presenting as an acute orbital mass in the medial rectus muscle.
Ehlers JP; Penne RB; Eagle RC; Carrasco JR
Ophthalmic Plast Reconstr Surg; 2007; 23(2):149-51. PubMed ID: 17413634
[TBL] [Abstract][Full Text] [Related]
38. Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma.
Krawczyk MA; Styczewska M; Sokolewicz EM; Kunc M; Gabrych A; Fatyga A; Izycka-Swieszewska E; Kazanowska B; Adamkiewicz-Drozynska E; Bien E
Biomarkers; 2019 Sep; 24(6):538-548. PubMed ID: 30995126
[No Abstract] [Full Text] [Related]
39. The utility of alpha-fetoprotein screening in Beckwith-Wiedemann syndrome.
Duffy KA; Deardorff MA; Kalish JM
Am J Med Genet A; 2017 Mar; 173(3):581-584. PubMed ID: 28160403
[TBL] [Abstract][Full Text] [Related]
40. Molecular analysis of a patient with Beckwith-Wiedemann syndrome, rhabdomyosarcoma and renal cell carcinoma.
Matsumoto T; Kinoshita E; Maeda H; Niikawa N; Kurosaki N; Harada N; Yun K; Sawai T; Aoki S; Kondoh T
Jpn J Hum Genet; 1994 Jun; 39(2):225-34. PubMed ID: 8086640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
